This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
25, 2021 (GLOBE NEWSWIRE) — Calibre Scientific is pleased to announce the acquisition of AIT France (“AIT”), a manufacturer and distributor of innovative consumables for analyticalchemistry and chromatography. LOS ANGELES, Jan. Our global reach extends into over 100 countries, empowering customers all over the world.
A: Drug development uses a lot of the same skills as forensic science—the analyticalchemistry, the problem-solving—with just a different application. Every time I learn of one of the drugs we’ve worked has moved into clinical trials or has gone to market, I'm further motivated. Q: What drew you to drug development?
We invited a panel of speakers to share their experience & insights, watch the video below to hear their insights: How do you recommend marketing your CV for moving over into a more commercial role? I have a year long masters project based within a CRO’s analyticalchemistry innovations department initially working in the lab.
FDA also notes variability in the approaches, inconsistent analyticalchemistry reports, and deficiencies in review of premarket submissions as a driver for the draft guidance. BEP/BER or Biological Risk Assessment) per ISO 10993-1 is not required for the majority of FDA pre-market submissions.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content